Cancilico raises €2.5M in Seed funding to enhance its AI diagnostic software MyeloAID. The round was led by High-Tech Gründerfonds and others.
Amount Raised
€2.5 Million
Round Type
Seed
DresdenBiotechnologyHealth CareInvestors
Description
Cancilico, a Dresden-based AI diagnostics startup specializing in blood cancer, secured €2.5M in Seed funding. The funding round was led by a consortium including High-Tech Gründerfonds and others. The company plans to use the funds to accelerate its AI-based diagnostic software MyeloAID and enhance digital biomarker development. Founded in 2023, Cancilico focuses on improving blood and bone marrow analysis accuracy.
Quick answer
Cancilico raised €2.5 Million in a Seed round, dated January 22, 2026. Investors: GEDAD GmbH, Roi Verwaltungsgesellschaft, Tgfs Technologiegründerfonds Sachsen and High Tech Gründerfonds. Cancilico is based in Dresden, Saxony, Germany.
- How much did Cancilico raise?
- Cancilico raised €2.5 Million in a Seed round on January 22, 2026.
- Who invested in Cancilico?
- GEDAD GmbH, Roi Verwaltungsgesellschaft, Tgfs Technologiegründerfonds Sachsen and High Tech Gründerfonds are named as investors in this round.
- What does Cancilico do?
- Cancilico is a Dresden, Germany-based AI diagnostics startup specializing in blood cancer.
- Where is Cancilico based and how big is it?
- Cancilico is based in Dresden, Saxony, Germany. Fundz records about 10 employees.
- Who are the decision-makers at Cancilico?
- Fundz holds 1 contact at Cancilico. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Cancilico that raised within 45 days of this round, from Fundz verified event records.
- Telo Genomics raised $7K (Pre-Seed) on March 6, 2026.
- NexCure raised $19M (Series A) on March 5, 2026.
- Raydiax raised $8.7M (Funding Round) on March 5, 2026.
- Prolium Bioscience raised $50M (Series A) on March 5, 2026.
- LifeCellsNI raised $790K (Pre-Seed) on March 4, 2026.
- Sonas Pharma raised an undisclosed amount (Pre-Seed) on March 4, 2026.
Who to call at Cancilico, and when
A new round usually means Cancilico is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cancilico raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cancilico, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cancilico. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cancilico raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cancilico raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.